Murray Dallan has filed 19 insider transactions across 1 company since May 2024.
Most recent transaction: a option exercise of 5500 shares of Sarepta Therapeutics, Inc. ($SRPT) on March 07, 2025.
Activity breakdown: 0 open-market purchases and 1 sale.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 7, 2025 | Sarepta Therapeutics, Inc. | $SRPT | Murray Dallan | Chief Customer Officer | M | Common Stock | 5500 | $0.00 | 33,659.0000 | 107,875,000 | 19.53% | 0.01% |
| March 10, 2025 | Sarepta Therapeutics, Inc. | $SRPT | Murray Dallan | Chief Customer Officer | F | Common Stock | 996 | $100.13 | 32,663.0000 | 107,875,000 | 2.96% | 0.00% |
| March 10, 2025 | Sarepta Therapeutics, Inc. | $SRPT | Murray Dallan | Chief Customer Officer | F | Common Stock | 2737 | $100.13 | 29,926.0000 | 107,875,000 | 8.38% | 0.00% |
| March 10, 2025 | Sarepta Therapeutics, Inc. | $SRPT | Murray Dallan | Chief Customer Officer | A | Common Stock | 8276 | $0.00 | 38,202.0000 | 107,875,000 | 27.65% | 0.01% |
| March 7, 2025 | Sarepta Therapeutics, Inc. | $SRPT | Murray Dallan | Chief Customer Officer | M | Performance Stock Units | 5500 | $0.00 | 0.0000 | 107,875,000 | 100.00% | 0.01% |
| March 10, 2025 | Sarepta Therapeutics, Inc. | $SRPT | Murray Dallan | Chief Customer Officer | A | Stock Options (right to buy) | 16644 | $0.00 | 16,644.0000 | 107,875,000 | 9999.99% | 0.02% |
| March 6, 2025 | Sarepta Therapeutics, Inc. | $SRPT | Murray Dallan | Chief Customer Officer | M | Common Stock | 17500 | $0.00 | 37,321.0000 | 107,875,000 | 88.29% | 0.02% |
| March 7, 2025 | Sarepta Therapeutics, Inc. | $SRPT | Murray Dallan | Chief Customer Officer | F | Common Stock | 549 | $103.70 | 36,772.0000 | 107,875,000 | 1.47% | 0.00% |
| March 7, 2025 | Sarepta Therapeutics, Inc. | $SRPT | Murray Dallan | Chief Customer Officer | F | Common Stock | 8613 | $103.70 | 28,159.0000 | 107,875,000 | 23.42% | 0.01% |
| March 6, 2025 | Sarepta Therapeutics, Inc. | $SRPT | Murray Dallan | Chief Customer Officer | M | Performance Stock Units | 17500 | $0.00 | 0.0000 | 107,875,000 | 100.00% | 0.02% |
| March 4, 2025 | Sarepta Therapeutics, Inc. | $SRPT | Murray Dallan | Chief Customer Officer | F | Common Stock | 1685 | $101.34 | 19,821.0000 | 107,875,000 | 7.84% | 0.00% |
| March 3, 2025 | Sarepta Therapeutics, Inc. | $SRPT | Murray Dallan | Chief Customer Officer | F | Common Stock | 711 | $103.77 | 21,506.0000 | 107,875,000 | 3.20% | 0.00% |
| Feb. 11, 2025 | Sarepta Therapeutics, Inc. | $SRPT | Murray Dallan | Chief Customer Officer | A | Performance Restricted Stock Units | 3500 | $0.00 | 17,500.0000 | 107,875,000 | 25.00% | 0.00% |
| June 21, 2024 | Sarepta Therapeutics, Inc. | $SRPT | Murray Dallan | Chief Customer Officer | M | Common Stock | 6250 | $0.00 | 24,375.0000 | 92,398,000 | 34.48% | 0.01% |
| June 24, 2024 | Sarepta Therapeutics, Inc. | $SRPT | Murray Dallan | Chief Customer Officer | F | Common Stock | 2352 | $164.64 | 22,023.0000 | 92,398,000 | 9.65% | 0.00% |
| June 21, 2024 | Sarepta Therapeutics, Inc. | $SRPT | Murray Dallan | Chief Customer Officer | A | Performance Stock Units | 5500 | $0.00 | 5,500.0000 | 92,398,000 | 9999.99% | 0.01% |
| June 21, 2024 | Sarepta Therapeutics, Inc. | $SRPT | Murray Dallan | Chief Customer Officer | A | Performance Stock Units | 6250 | $0.00 | 6,250.0000 | 92,398,000 | 9999.99% | 0.01% |
| June 21, 2024 | Sarepta Therapeutics, Inc. | $SRPT | Murray Dallan | Chief Customer Officer | M | Performance Stock Units | 6250 | $0.00 | 0.0000 | 92,398,000 | 100.00% | 0.01% |
| May 2, 2024 | Sarepta Therapeutics, Inc. | $SRPT | Murray Dallan | Chief Customer Officer | S | Common Stock | 3635 | $140.00 | 18,125.0000 | 92,398,000 | 16.70% | 0.00% |